Trial Profile
A retrospective trial to study efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 06 Dec 2015 New trial record